|
1）Hoei-Hansen CE, Sehested A, Juhler M, et al. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol. 2006; 209: 25-33
|
|
|
|
2）Rosenblum MK, Nakazato Y, Matsutani M. CNS germ cell tumours. In: Louis DN, Ohgaki L, Wiestler D, et al, editors. WHO Classification of Tumours of the Central Nervous System. Lyon: International Agency for Research on Cancer; 2007. p.197-204
|
|
|
|
|
|
3）Dolecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol. 2012; 14 Suppl 5: v1-49
|
|
|
|
|
|
4）Kamakura Y, Hasegawa M, Minamoto T, et al. C-kit gene mutation: common and widely distributed in intracranial germinomas. J Neurosurg. 2006; 104: 173-80
|
|
|
|
|
|
5）Sakuma Y, Sakurai S, Oguni S, et al. c-kit gene mutations in intracranial germinomas. Cancer Sci. 2004; 95: 716-20
|
|
|
|
|
|
6）Okada Y, Nishikawa R, Matsutani M, et al. Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. J Neuropathol Exp Neurol. 2002; 61: 531-8
|
|
|
|
|
|
7）Schneider DT, Zahn S, Sievers S, et al. Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod Pathol. 2006; 19: 864-73
|
|
|
|
|
|
8）Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013; 155: 462-77
|
|
|
|
|
|
9）Sturm D, Witt H, Hovestadt V, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012; 22: 425-37
|
|
|
|
|
|
10）Northcott PA, Shih DJ, Peacock J, et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 2012; 488: 49-56
|
|
|
|
|
|
11）Robinson G, Parker M, Kranenburg TA, et al. Novel mutations target distinct subgroups of medulloblastoma. Nature. 2012; 488: 43-8
|
|
|
|
|
|
12）Wang L, Yamaguchi S, Burstein MD, et al. Novel somatic and germline mutations in intracranial germ cell tumours. Nature. 2014; 511: 241-5
|
|
|
|
|
|
13）Fukushima S, Otsuka A, Suzuki T, et al. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas. Acta Neuropathol. 2014; 127: 911-25
|
|
|
|
|
|
14）Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer. 2011; 11: 865-78
|
|
|
|
|
|
15）Terashima K, Yu A, Chow WY, et al. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors. Pediatr Blood Cancer. 2014; 61: 593-600
|
|
|
|
|
|
16）Rodriguez S, Jafer O, Goker H, et al. Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p)and amplification at 12p11.2-p12.1. Oncogene. 2003; 22: 1880-91
|
|
|
|
|
|
17）Zafarana G, Grygalewicz B, Gillis AJ, et al. 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene. 2003; 22: 7695-701
|
|
|
|
|
|
18）Rickert CH, Simon R, Bergmann M, et al. Comparative genomic hybridization in pineal germ cell tumors. J Neuropathol Exp Neurol. 2000; 59: 815-21
|
|
|
|
|
|
19）Maeda Y, Yoshikawa K, Kajiwara K, et al. Intracranial yolk sac tumor in a patient with Down syndrome. J Neurosurg Pediatr. 2011; 7: 604-8
|
|
|
|
|
|
20）Kaido T, Sasaoka Y, Hashimoto H, et al. De novo germinoma in the brain in association with Klinefelterʼs syndrome: case report and review of the literature. Surg Neurol. 2003; 60: 553-8; discussion 9
|
|
|
|
|
|
21）Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005; 5: 210-22
|
|
|
|
|
|
22）金田正弘, 佐々木裕之．生殖細胞とゲノムインプリンティング．実験医学（増刊）．2006; 24: 146-51
|
|
|
|
|
|
23）Hovestadt V, Remke M, Kool M, et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 2013; 125: 913-6
|
|
|
|
|
|
24）Korshunov A, Ryzhova M, Hovestadt V, et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol. 2015; 129: 669-78
|
|
|
|
|
|
25）Mack SC, Witt H, Piro RM, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 2014; 506: 445-50
|
|
|
|
|
|
26）Pietsch T, Schmidt R, Remke M, et al. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol. 2014; 128: 137-49
|
|
|
|
|
|
27）Smiraglia DJ, Szymanska J, Kraggerud SM, et al. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene. 2002; 21: 3909-16
|
|
|
|
|
|
28）Lee SH, Appleby V, Jeyapalan JN, et al. Variable methylation of the imprinted gene, SNRPN, supports a relationship between intracranial germ cell tumours and neural stem cells. J Neurooncol. 2011; 101: 419-28
|
|
|
|
|
|
29）Tan C, Scotting PJ. Stem cell research points the way to the cell of origin for intracranial germ cell tumours. An alternative cell of origin for intracranial germ cell tumours. J Pathol. 2013; 229: 4-11
|
|
|
|
|
|
30）Rijlaarsdam MA, Tax DM, Gillis AJ, et al. Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors. PLoS One. 2015; 10: e0122146
|
|
|
|
|